Stocktoria

CVS HEALTH Corp CVS

NYSE · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 1952-10-01 · LEI

CVS HEALTH Corp (CVS) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 2.55% (safety: at-risk). FY2025 revenue was $402.1B at a 0.4% net margin.

Chart by TradingView
34/100
Stocktoria Quality Score · grade D
5/9
Piotroski F — financial health
0.99
Altman Z″ — distress risk · distress
3.2%
Dividend yield 5y avg · at-risk · Dividend payout 192.1%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
6 6 3 6 5 5 6 6 5 5 2016201720182019202020212022202320242025
Altman Z″
2.90 1.30 1.36 1.40 1.43 1.41 1.34 1.07 0.99 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$94.72 as of 2026-08-01 · +29.5% 1y
$71.82$104.4352-wk
Market cap USD$133.1B
P / E75.3×
Dividend yield 5y avg3.2%
Net margin 5y avg1.6%
Return on equity 5y avg7.2%
Beta0.6
Employees219,000

Analyst price target

$115.80 +22.3% vs last
consensus: strong buy · 25 analysts
target range $103.00 – $148.00 · median $113.00
6 strong buy · 18 buy · 3 hold
Recent analyst actions
DateFirmRating
2026-08-12JP MorganOverweight (main)
2026-08-06UBSBuy (main)
2026-08-06Evercore ISI GroupOutperform (main)
2026-08-06BarclaysOverweight (main)
2026-07-25UBSBuy (main)
2026-07-14Truist SecuritiesBuy (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$8.50
Forward P / E11.1×

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Smart money · insiders, last 12 months

Insiders net sold -$317.5M on the open market · 7 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Retail Trade · percentile among 238 companies

Piotroski Fstronger than 45%
Net marginstronger than 40%
Return on equitystronger than 36%
Revenue growthstronger than 69%

Percentile vs other Retail Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets-0.055
Retained earnings / assets0.241
EBIT / assets0.018
Equity / liabilities0.423

Sector peers · similar-size Retail Trade companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
CVSCVS HEALTH Corp5/90.9975.3+7.8%
YI111, Inc.2/9-5.73-9%
GRDNGuardian Pharmacy Services, Inc.6/93.8554.4+17.9%
PETSPETMED EXPRESS INC2/9-4.59-21.1%
RDGTRidgetech Inc.6/90.16+10.2%
CANNTREES Corp (Colorado)3/9-16.65+34.9%
WMTWalmart Inc.6/92.0144+4.7%

All Retail Trade companies →

About CVS HEALTH Corp

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

FAQ

Is CVS financially healthy?

CVS HEALTH Corp's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does CVS pay a dividend, and is it safe?

Yes. CVS HEALTH Corp pays a dividend yielding about 2.55% with a 192.1% payout ratio, rated “at-risk” for safety.

How profitable is CVS?

In FY2025, CVS HEALTH Corp had a net margin of 0.4% and a return on equity of 2.3%.

Is CVS overvalued or undervalued?

CVS HEALTH Corp trades at about 68.1× trailing earnings — above its 10-year norm (10-year range 11.5×–53.6×, median 16.1×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for CVS?

The average Wall-Street price target for CVS HEALTH Corp is $115.80, about 22.3% above the recent price, from 25 analysts (consensus: strong buy).

Is CVS a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on CVS HEALTH Corp: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone, a P/E of about 75.3×, a dividend yield of 2.55%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.